NCT02422875View on ClinicalTrials.gov

Comparative Autoantibody and Immunologic Cell Marker Study

Enrolling by invitationOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
Autoimmune DiseasesLupus Erythematosus, SystemicCommunicable Diseases
Trial Locations (3)

30322

Emory University Hospital, Atlanta

Emory University Winship Cancer Institute, Atlanta

Grady Health System, Atlanta

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Emory University

OTHER